Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

13.88p
   
  • Change Today:
      0.75p
  • 52 Week High: 32.50
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 769,296
  • Market Cap: £57.23m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
08-Aug-25 Transfer To Richard John Rees 0.000p 362,408 £0.00
22-Jul-25 Transfer From Richard John Rees 0.000p 12,858 £0.00
22-Jul-25 Sell Richard John Rees 14.00p 6,429 £900.06
22-Jul-25 Transfer From Craig Jonathan Gulliford 0.000p 12,858 £0.00
22-Jul-25 Sell Craig Jonathan Gulliford 14.00p 6,429 £900.06

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
22-Jul-25 Sell Craig Jonathan Gulliford 14.00p 6,429 £900.06
22-Jul-25 Sell Richard John Rees 14.00p 6,429 £900.06
08-Aug-25 Transfer To Richard John Rees 0.000p 362,408 £0.00
22-Jul-25 Transfer From Craig Jonathan Gulliford 0.000p 12,858 £0.00
22-Jul-25 Transfer From Richard John Rees 0.000p 12,858 £0.00

Director Shareholdings

Notifier Holding Value*
Kevin Crofton 5,447,416 £755,829
Richard John Rees 2,707,555 £375,673
Craig Jonathan Gulliford 1,679,765 £233,067
Charles Spicer 308,530 £42,808
Ivonne Cantu 125,000 £17,344

Major Shareholders

Notifier** Holding Value*
M&G Investments 47,478,836 £6,587,688
Canaccord Genuity Group Inc 36,014,293 £4,996,983
River Global Investors LLP 20,827,081 £2,889,758
Development Bank of Wales plc 14,376,727 £1,994,771
Finance Wales 12,776,727 £1,772,771
Baillie Gifford & Co 12,537,441 £1,739,570
Creo Medical Group EBT 10,000,000 £1,387,500
The Capital Group Companies, Inc. 8,816,807 £1,223,332
AXA Framlington Investment Managers 7,992,961 £1,109,023
Hargreave Hale Limited 6,753,632 £937,066
Tellworth Investments 5,772,778 £800,973
Hoya Corporation 4,799,880 £665,983
Jonathan Craton 3,400,294 £471,791
Cotterford Co Limited 3,335,398 £462,786
Mark Farmer 3,121,607 £433,123
RBC Trustees (CI) Ltd 2,974,727 £412,743
Angel Co Fund 2,967,120 £411,688

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 13.88p
Change Today 0.75p
% Change 5.71 %
52 Week High 32.50
52 Week Low 9.55
Volume 769,296
Shares Issued 412.47m
Market Cap £57.23m
Beta 0.00

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.20% above the market average6.20% above the market average6.20% above the market average6.20% above the market average6.20% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
80.54% below the market average80.54% below the market average80.54% below the market average80.54% below the market average80.54% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average
Income Not Available
Growth
46.99% below the market average46.99% below the market average46.99% below the market average46.99% below the market average46.99% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 15-Aug-2025

Time Volume / Share Price
16:15 2,225 @ 13.75p
16:15 7 @ 13.75p
16:15 100 @ 14.00p
16:05 25,000 @ 13.93p
15:38 9,683 @ 14.00p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page